These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9829415)
1. Technique of, and complications attributable to, repeated hyperosmotic blood-brain barrier disruption in dogs. Culver B; Inzana K; Jones J; Troy G; Kroll R; Culver B; Jortner B Am J Vet Res; 1998 Nov; 59(11):1503-10. PubMed ID: 9829415 [TBL] [Abstract][Full Text] [Related]
2. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365 [TBL] [Abstract][Full Text] [Related]
3. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316 [TBL] [Abstract][Full Text] [Related]
4. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate. Sage MR; Wilcox J; Evill CA; Benness GT Invest Radiol; 1982; 17(3):276-81. PubMed ID: 6811497 [TBL] [Abstract][Full Text] [Related]
5. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis. Kozler P; Pokorný J Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531 [TBL] [Abstract][Full Text] [Related]
6. Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Galor A; Ference SJ; Singh AD; Lee MS; Stevens GH; Perez VL; Peereboom DM Am J Ophthalmol; 2007 Jul; 144(1):45-49. PubMed ID: 17601426 [TBL] [Abstract][Full Text] [Related]
7. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats. Pan GY; Liu XD; Liu GQ Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668 [TBL] [Abstract][Full Text] [Related]
8. Increased blood-brain permeability with hyperosmolar mannitol increases cerebral O2 consumption and O2 supply/consumption heterogeneity. Chi OZ; Wei HM; Lu X; Weiss HR J Cereb Blood Flow Metab; 1996 Mar; 16(2):327-33. PubMed ID: 8594066 [TBL] [Abstract][Full Text] [Related]
9. Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy. Joshi S; Ergin A; Wang M; Reif R; Zhang J; Bruce JN; Bigio IJ J Neurooncol; 2011 Aug; 104(1):11-9. PubMed ID: 21153681 [TBL] [Abstract][Full Text] [Related]
10. Lack of autoregulatory response of the cerebral circulation after osmotic opening of the blood-brain barrier in dogs. Koźniewska E; Skolasińska K Acta Physiol Pol; 1980; 31(4):383-9. PubMed ID: 7446151 [TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier disruption in the treatment of brain tumors. Blanchette M; Fortin D Methods Mol Biol; 2011; 686():447-63. PubMed ID: 21082387 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma. Volopich S; Mosing M; Auer U; Nell B Vet Ophthalmol; 2006; 9(4):239-44. PubMed ID: 16771759 [TBL] [Abstract][Full Text] [Related]
14. Perioperative complications of blood brain barrier disruption under general anesthesia: a retrospective review. Elkassabany NM; Bhatia J; Deogaonkar A; Barnett GH; Lotto M; Maurtua M; Ebrahim Z; Schubert A; Ference S; Farag E J Neurosurg Anesthesiol; 2008 Jan; 20(1):45-8. PubMed ID: 18157025 [TBL] [Abstract][Full Text] [Related]
15. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate. Preston E; Slinn J; Vinokourov I; Stanimirovic D J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299 [TBL] [Abstract][Full Text] [Related]
16. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke. Chen CH; Toung TJ; Sapirstein A; Bhardwaj A J Cereb Blood Flow Metab; 2006 Jul; 26(7):951-8. PubMed ID: 16306935 [TBL] [Abstract][Full Text] [Related]
17. A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models. Blanchette M; Michaud K; Fortin D J Neurosci Methods; 2012 Jun; 207(2):125-9. PubMed ID: 22521326 [TBL] [Abstract][Full Text] [Related]
18. Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Neuwelt EA; Rapoport SI Fed Proc; 1984 Feb; 43(2):214-9. PubMed ID: 6692941 [TBL] [Abstract][Full Text] [Related]
19. [Recirculation in the acute period of cerebral infarction: experimental research--brain swelling and its suppression using mannitol and glycerol (author's transl)]. Tanaka S; Yoshimoto T; Suzuki J No Shinkei Geka; 1980 Jul; 8(7):633-8. PubMed ID: 6774275 [TBL] [Abstract][Full Text] [Related]
20. The somatosensory evoked potential as a noninvasive method to determine flow rates for hyperosmotic disruption of the blood-brain barrier. Warnke PC; Phillips A; Bernstein LP; Groothuis DR Neurosurgery; 1989 Sep; 25(3):405-11. PubMed ID: 2505161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]